Clinical Trials Browser

Phase 2 × Biliary Tract Neoplasms × 30 days × Clear all

NCT06760819 2026-06-04

panSOHO

Phase 2 Recruiting

BreastGastrointestinalGenitourinaryGynecologicSarcoma

Biliary Tract Neoplasms, Urinary Bladder Neoplasms, Breast Neoplasms, Uterine Cervical Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Gastrointestinal Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Gastrointestinal Stromal Tumors

NCT03801083 2026-06-01

Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers

Phase 2 Active not recruiting

Gastrointestinal

Biliary Tract Neoplasms, Cholangiocarcinoma

NCT06465563 2026-05-29

SHR-8068 in Combination With Adebrelimab, Bevacizumab, and Platinum-Based Chemotherapy as First-line Treatment in Patients With Advanced Biliary Tract Cancer

Phase 2 Active not recruiting

Gastrointestinal

Biliary Tract Neoplasms

NCT07599995 2026-05-20

GENE

Phase 2 Not yet recruiting

Gastrointestinal

Biliary Tract Neoplasms

NCT06529718 2026-05-19

SEVILLA

Phase 2 Recruiting

Gastrointestinal

Biliary Tract Neoplasms, Cholangiocarcinoma

NCT05512377 2026-05-14

Brightline-2: A Study to Test Whether Brigimadlin (BI 907828) Helps People With Cancer in the Biliary Tract, Pancreas, Lung or Bladder

Phase 2 Terminated

GastrointestinalGenitourinaryThoracic

Biliary Tract Neoplasms, Urinary Bladder Neoplasms, Lung Neoplasms, Pancreatic Neoplasms